COMP <GO>
JAZZ vs UNH // 10Y YIELD & FRED MACRO BETA
Jazz Pharmaceuticals plc (Ireland) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: JAZZ 2
— UNH 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: JAZZ
LAST: $207.83 (+1.35%) • MKT CAP: $13.49B
macro-sensitivity
1.09
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAZZ VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAZZ | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.70% | 11.47% | -16.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 9.61% | 6.48% | +3.13 | JAZZ | /fcf-yield <GO> |
| Operating Margin | -10.10% | 4.82% | -14.92 | UNH | /operating-margins <GO> |
| Net Profit Margin | -8.30% | 3.14% | -11.44 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 4.90% | 6.46% | -1.56 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.97 | 3.12 | -1.15 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.2 | 59.2 | -20.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.09 | 0.33 | +0.76 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 17.1x | +18.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.49B | $368.83B | -$355.34B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAZZ REV | UNH REV | JAZZ GROSS % | UNH GROSS % | JAZZ FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.27B | $447.57B | — | 88.7% | $1.30B | $16.07B |
| FY 2024 | $4.07B | $400.28B | — | 88.3% | $1.36B | $20.70B |
| FY 2023 | $3.83B | $371.62B | — | 89.6% | $919.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAZZ // BETA 1.09
UNH // BETA 0.33